Breaking news

In this review, the authors update the neurological mechanisms by which coronavirus-19 causes neurological manifestation in patients such as encephalomyelitis, Guillain-Barré syndrome, lacunars infarcts, neuropsychiatry disorders such as anxiety and depression, and vascular alterations.

This retrospective study evaluates the severity and outcome of COVID-19 in MS and characterizes temporal trends over the course of the pandemic in the United States.

The authors developed an interferon (IFN)-γ release assay to detect T-cell responses specific to SARS-CoV-2 after overnight stimulation of whole blood with peptide libraries covering the immunodominant sequence domains of the Spike glycoprotein and the Nucleocapsid phosphoprotein.

This study investigated the vaccine hesitancy and coping styles in patients with NMOSD to analyze the relationship between vaccine hesitancy and coping styles, and elucidate the factors influencing vaccine hesitancy.

In this article the authors systematically reviewed and meta-analyzed variations in stroke admissions, rate and timing of reperfusion treatments during the 1st-wave COVID pandemic versus the pre-pandemic timeframe depending on stroke network model adopted.

The aim of this study was to determine the influence of high-efficacy disease modifying therapy on the development of IgG SARS-CoV-2 antibody response in COVID-19 convalescent people with multiple sclerosis.

In this article the authors aimed to study headache character in relation to COVID-19. This was a cross-sectional study.

Using a cross-sectional questionnaire study, the authors examined the experience of patients with PNES at a single Comprehensive Epilepsy Center in New York City.

In this article the authors present 5 cases of COVID-19-associated myelitis with tract-specific involvement of the dorsal and lateral columns and discuss potential pathophysiologic pathways for this unique pattern.

COVID-19 has been associated with various neurological and atypical HEENT (head/eyes/eyes/nose/throat) manifestations. In this systematic review and meta-analysis the authors sought to review the evidence for these manifestations.

In this article the authors aimed to evaluate the effects of the COVID-19 pandemic on the quality of life (QoL) and perceived disease burden of this group of patients.

In this article the authors performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants.

Jes Olensen, clinical professor in the department of clinical neurology, Rigshospitalet, Denmark, has been awarded the Brain Prize along with Michael Moskowitz, Lars Edvinsson and Peter Goadsby for discovering a key mechanism that causes migraine which has since led to revolutionary new treatments.

In this nice paper recently published in the European Journal of Neurology, the authors systematically reviewed available evidence for reports of neurological signs and symptoms in COVID‐19 patients to identify cases with SARS‐CoV‐2 infection or immune‐mediated reaction in the nervous system.

COVID-19 AND NEUROLOGY Because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing… Continue Reading